低氧促进肺腺癌A549细胞迁移的机制*

doi:10.12047/j.cjap.6200.2022.013

摘要/Abstract

摘要： 目的: 探讨低氧促进肺腺癌A549细胞迁移的机制。方法: 培养肺腺癌A549细胞,转染慢病毒获得稳定敲低ACC1的A549细胞株,转染si-RNA获得敲低SREBP-1的A549细胞。分别以低氧(5％ O₂)联合低氧诱导因子1α(HIF-1α)抑制剂PX-478(25 μmol)处理A549细胞,低氧联合亚油酸(LA)(20 μmol)处理敲低ACC1的A549细胞,低氧处理敲低胆固醇调节原件结合蛋白1(SREBP-1)的A549细胞。Transwell实验检测细胞迁移,蛋白质印迹法检测HIF-1α、ACC1及上皮-间质转化(EMT)相关波形蛋白(Vimentin)及E-钙黏蛋白(E-Cadherin)的表达与SREBP-1的表达,实时荧光定量聚合酶链反应(RT-qPCR)检测低氧联合HIF-1α抑制剂PX-478(25 μmol)处理A549细胞后ACC1及SREBP-1 mRNA水平变化。每项实验重复三次。结果: 与常氧组相比,低氧组A549细胞迁移数增加,ACC1与HIF-1α表达上调(P均＜0.01),SREBP-1表达上调(P＜0.05);与低氧对照组相比,PX-478(25 μmol)抑制A549细胞迁移,SREBP-1表达下调(P＜0.05);低氧处理A549细胞后ACC1 mRNA上升(P＜0.05),SREBP-1 mRNA水平上升(P＜0.01);低氧并使用PX-478(25 μmol)处理A549细胞24 h,ACC1 mRNA水平下降(P＜0.05),SREBP-1 mRNA 水平下降(P＜0.01);转染si-RNA获得敲低SREBP-1的A549细胞,Transwell 实验显示si-SREBP-1组细胞迁移数较常氧对照组减少(P＜0.01);低氧处理si-SREBP-1组与si-NC组,与对照组相比si-SREBP-1组细胞迁移数减少(P＜0.01)但与常氧组相比差异无统计学意义(P＞0.05);Western blot检测到si-SREBP-1组ACC1表达较对照组下降(P＜0.01);低氧处理si-SREBP-1组,ACC1表达较对照组下降(P＜0.01);敲低ACC1抑制A549细胞迁移(P＜0.05),敲低ACC1后A549细胞在常氧和5％ O₂条件下细胞迁移数目差异无统计学意义(P＞ 0.05);低氧处理敲低ACC1的A549细胞并给予LA(25 μmol)促进A549细胞迁移(P＜0.05)。结论: 低氧通过HIF-1α/SREBP-1/ACC1途径调节脂肪酸代谢进而促进肺腺癌A549细胞迁移。

关键词: 肺腺癌, 低氧, 乙酰辅酶A羧化酶1, 低氧诱导因子1α, 固醇调节元件结合蛋白1, 迁移

Abstract: Objective: To investigate the mechanism that hypoxia promotes the migration of lung adenocarcinoma A549 cells. Methods: A549 cells were cultured and cells that knockdown of acetyl-CoA carboxylase 1 (ACC1) were obtained by transfection with lentivirus, and cells that knockdown of sterol regulatory element-binding proteins-1 (SREBP-1) were obtained by treated with si-RNA. A549 cells were treated with hypoxia combined with hypoxia inducible factor-1α (HIF-1α) inhibitor PX-478 (25 μmol); Hypoxia combined with linoleic acid (LA) (20 μmol) treated A549 cells with ACC1 knockdown, and A549 cells with SREBP-1 knockdown were treated by hypoxia. Transwell migration assay was used to detect cell migration. Western blot was conducted to detect HIF-1α, ACC1 and epithelial mesenchymal transition (EMT) related proteins, Vimentin, E-Cadherin and SREBP-1; Real-time fluorescent quantitative polymerase chain reaction (RT-qPCR) was performed to detect the changes of ACC1 and SREBP-1 mRNA in A549 cells after hypoxia and HIF-1α inhibitor PX-478 (25 μmol) treatment. Each experiment was repeated three times. Results: Compared with the normoxic control group, hypoxia promoted the migration of A549 cells (P＜0.01), and up-regulated the expressions of ACC1, HIF-1α (all P＜0.01) and SREBP-1 (P＜0.05). PX-478 (25 μmol) inhibited the migration of A549 cells induced by hypoxia and down-regulated the expression of SREBP-1 (all P＜0.05). ACC1 mRNA and SREBP-1 mRNA levels were increased after hypoxia treatment of A549 cells (all P＜0.05). The levels of ACC1 mRNA and SREBP-1 mRNA were decreased after A549 cells treated with hypoxia combined with PX-478 (25 μmol) for 24 h (P＜0.05, P＜0.01). Knockdown of SREBP-1 in A549 cells was obtained by transfection with si-RNA. Transwell migration assay showed the number of cell migration in si-SREBP-1 group was less than that in normoxia control group (P＜0.01). The si-SREBP-1 group and the si-NC group were treated with hypoxia. Compared with the control group, the number of cell migration in the si-SREBP-1 group was decreased (P＜0.01), however, the difference was not statistically significant compared with the normoxia si-SREBP-1 group (P＞0.05). Western blot showed that the expression of ACC1 in the si-SREBP-1 group was lower than that in the control group (P＜0.01). Compared with the control group, the expression of ACC1 was decreased after si-SREBP-1 group treated with hypoxia (P＜0.01). Knockdown of ACC1 inhibited the migration of A549 cells (P＜0.05). After knockdown of ACC1, the migration number of A549 cells under normoxia and 5% O₂ conditions had no significant difference (P＞0.05). Application of LA under hypoxia condition rescued ACC1-knockdown induced inhibitory effect on hypoxia-promoted A549 cell migration (P＜0.05). Conclusion: Hypoxia promotes migration of lung adenocarcinoma A549 cells by regulating fatty acid metabolism through HIF-1α/SREBP-1/ACC1 pathway.

Key words: lung adenocarcinoma, hypoxia, acetyl-CoA carboxylase 1, hypoxia inducible factor 1 α, sterol regulatory element binding protein 1, migration

中图分类号:

R734-2

金家豪, 赵宝生, 刘玉珍. 低氧促进肺腺癌A549细胞迁移的机制^*[J]. 中国应用生理学杂志, 2022, 38(1): 68-74.

JIN Jia-hao, ZHAO Bao-sheng, LIU Yu-zhen. Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells[J]. CJAP, 2022, 38(1): 68-74.

参考文献

[1] Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship[J]. Mayo Clin Proc, 2008, 83(5): 584-594.
[2] Eggert JA, Palavanzadeh M, Blanton A. Screening and early detection of lung cancer[J]. Semin Oncol Nurs, 2017, 33(2): 129-140.
[3] Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro[J]. Cancer Res, 1953, 13(1): 27-29.
[4] Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer[J]. Br J Cancer, 2020, 122(1): 4-22.
[5] Sormendi S, Wielockx B. Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment[J]. Front Immunol, 2018, 29: 9-40.
[6] Zuo J, Wen J, Lei M, et al. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT[J]. Med Oncol, 2016, 33(2): 15.
[7] Liu L, Ning X, Sun L, et al. Hypoxia inducible factor1- 1α contributes to hypoxia-induced chemoresistance in gastric cancer[J]. Cancer Sci, 2008, 99(1): 121-128.
[8] 金家豪, 赵宝生, 刘丹辉, 等. 低氧通过上调乙酰辅酶A羧化酶1促进肺腺癌A549细胞迁移[J]. 解剖学报, 2021, 52(2): 258-263.
[9] McGuirk S, Audet-Delage Y, St-Pierre J. Metabolic fitness and plasticity in cancer progression[J]. Trends Cancer, 2020, 6(1): 49-61.
[10] Junttila MR, de Sauvage FJ.Influence of tumour micro-environment heterogeneity on therapeutic response[J]. Nature, 2013, 501(7467): 346-354.
[11] Dutta A, Sharma-Walia N. Curbing lipids: Impacts on cancer and viral infection[J]. Int J Mol Sci, 2019, 20(3): 644.
[12] Tang Z, Xu Z, Zhu X, et al. New insights into molecules and pathways of cancer metabolism and therapeutic implications[J]. Cancer Commun (Lond), 2021, 41(3): 16-36.
[13] Wang J, Wu X. The effects of mitochondrial dysfunction on energy metabolism switch by HIF-1α signalling in granulosa cells of polycystic ovary syndrome[J]. Endokrynol Pol, 2020, 71(2): 134-145.
[14] Ezzeddini R, Taghikhani M, Somi MH, et al. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma[J]. Life Sci, 2019, 224(1): 169-176.
[15] Guo D, Bell EH, Mischel P, et al. Targeting SREBP-1-driven lipid metabolism to treat cancer[J]. Curr Pharm Des, 2014, 20(15): 2619-2626.
[16] Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology- divergent pathophysiology[J]. Nat Rev Endocrinol, 2017, 13(12): 710-730.
[17] Cheng C, Geng F, Cheng X, et al. Lipid metabolism reprogramming and its potential targets in cancer[J]. Cancer Commun (Lond), 2018, 38(1): 27.
[18] Hapke RY, Haake SM. Hypoxia-induced epithelial to mesenchymal transition in cancer[J]. Cancer Lett, 2020, 487(1): 10-20.
[19] Hunkeler M, Hagmann A, Stuttfeld E, et al. Structural basis for regulation of human acetyl-CoA carboxylase[J]. Nature, 2018, 558(7710): 470-474.
[20] Svensson RU, Parker SJ, Eichner LJ, et al. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models[J]. Nat Med, 2016, 22(10): 1108-1119.
[21] Altea-Manzano P, Cuadros AM, Broadfield LA, et al. Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take[J]. EMBO Rep, 2020, 21(10): e50635.
[22] 颜新建, 李高峰, 唐梅, 等. 下调脂肪酸合成酶表达对膀胱癌UMUC3细胞增殖、迁移及侵袭能力的影响[J].中国应用生理学杂志, 2019, 35(6): 543-547.
[23] Greenlee JD, Subramanian T, Liu K, et al. Rafting down the metastatic cascade: The role of lipid rafts in cancer metastasis, cell death, and clinical outcomes[J]. Cancer Res, 2021, 81(1): 5-17.
[24] 宋海岩, 张毅敏, 连辉, 等. 低氧条件下奥巴克拉联合吉西他滨对乳腺癌细胞的作用[J]. 中国应用生理学杂志, 2020, 36(3): 268-272.
[25] Saxena K, Jolly MK, Balamurugan K. Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis[J]. Transl Oncol, 2020, 13(11): 100845.

低氧促进肺腺癌A549细胞迁移的机制^*

Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	胡佳楠, 姜辉, 李美琦, 朱俐, 骆倩倩. 模拟高原低氧环境对小鼠脾脏铁代谢的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 628-631.
[2]	丁利平, 韩莹, 成祥, 赵彤, 朱玲玲, 廖红. 低氧联合LPS刺激对星形胶质细胞中炎性因子和BNIP3表达的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 632-637.
[3]	张自新, 陆海洋, 杨治花, 刘长虎, 詹文华, 折虹, 赵仁. RPA1低表达对辐射抵抗人鼻咽癌CNE-2R细胞侵袭迁移及细胞周期的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 490-494.
[4]	李洪霞, 刘芳, 夏俊华. miR-670-5p对肺癌细胞增殖、迁移、侵袭的影响[J]. 中国应用生理学杂志, 2021, 37(5): 500-505.
[5]	陆润兰, 李萍, 李兵, 邢媛, 张媛媛, 陈斌泽, 胡秦妮, 杨志华, 高保东, 哈小琴, 高彩燕. 海拔高度对2型糖尿病患者循环内皮祖细胞及低氧诱导因子的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 529-533.
[6]	吕烨, 孙小婉, 张聪, 栾志琳. Sox11基因对发育期小鼠大脑皮层神经元迁移的影响[J]. 中国应用生理学杂志, 2021, 37(4): 337-342.
[7]	陈郁, 龚亮, 罗勇军. 低氧mtDNA3010A/G基因型变异诱导的lncRNA-mRNA共表达网络变化[J]. 中国应用生理学杂志, 2021, 37(4): 343-348.
[8]	陈甄, 张广波, 周迪, 成祥, 朱玲玲, 范明, 王笃明, 赵永岐. 急性高原低氧环境对不同情绪状态脑电功率的影响^*[J]. 中国应用生理学杂志, 2020, 36(6): 556-561.
[9]	谭建军, 隆姝孜, 张涛. LncRNA UNC5B-AS1对肺癌细胞黏附、侵袭及迁移的影响及其机制^*[J]. 中国应用生理学杂志, 2020, 36(6): 622-627.
[10]	聂永莉, 汤世敏, 彭芳, 许涛, 毛永荣. miRNA-191对前列腺癌的增殖、迁移侵袭能力的影响及其机制^*[J]. 中国应用生理学杂志, 2020, 36(6): 637-641.
[11]	李杰茹, 任静, 杨胜昌, 韩聚强, 郭亚净, 吉恩生. 消痰化瘀利窍中药组方对改善慢性间歇性低氧大鼠心肌纤维化的作用及其机制^*[J]. 中国应用生理学杂志, 2020, 36(5): 414-418.
[12]	贾祥磊, 刘玉珍, 李超红, 范娅楠. 多巴胺对急性间歇性低氧诱导的大鼠颈动脉体低氧敏感性的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 428-431.
[13]	谢亚磊, 梅颂, 熊艳蕾, 刘诗颖, 徐成丽. 模拟海拔5 500 m低压低氧环境对大鼠HPT轴和肠道菌群的影响^*[J]. 中国应用生理学杂志, 2020, 36(5): 432-437.
[14]	张晓金, 张文霞, 朱吉玲, 罗文盼. 环状GMP-AMP合成酶高表达对乳腺癌细胞上皮间质转化的影响^*[J]. 中国应用生理学杂志, 2020, 36(4): 336-339.
[15]	宋海岩, 张毅敏, 连辉, 周立. 低氧条件下奥巴克拉联合吉西他滨对乳腺癌细胞的作用[J]. 中国应用生理学杂志, 2020, 36(3): 268-272.